United States

FFO (TTM)

FFO/share (TTM)

FFO (Quarter)

FFO/share (Quarter)

Price per share at the end of the period divided by the last reported earnings

Price/FFO

Size (ft²)

Occupancy

The Company’s primary strategy is to continue to focus on diversification of its assets through development of transit-centric, residential mixed-use projects in the Washington, D.C. metropolitan area. The Company’s operating strategy also includes improvement of the operating performance and internal growth of its Shopping Centers and will supplement its development of residential mixed-used projects with selective redevelopment and renovations of its core Shopping Centers.

Saul Centers

The main earnings metric reported by the REIT

If the REIT is managed by an internal (employees) or external (separate company) team

Period: 2022 Q3

Years since IPO: 15/15,
FFO Growth: 15/15,
FFO/share Growth: 5/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2022 Q4

Years since IPO: 15/15,
FFO Growth: 13/15,
FFO/share Growth: 3/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 5/15
            

Period: 2023 Q1

Years since IPO: 15/15,
FFO Growth: 10/15,
FFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 5/15
            

Period: 2023 Q2

Years since IPO: 15/15,
FFO Growth: 10/15,
FFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2023 Q3

Years since IPO: 15/15,
FFO Growth: 10/15,
FFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2023 Q4

Years since IPO: 15/15,
FFO Growth: 13/15,
FFO/share Growth: 18/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2024 Q1

Years since IPO: 15/15,
FFO Growth: 15/15,
FFO/share Growth: 20/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2024 Q2

Years since IPO: 15/15,
FFO Growth: 15/15,
FFO/share Growth: 20/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2024 Q3

Years since IPO: 15/15,
FFO Growth: 15/15,
FFO/share Growth: 20/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2024 Q4

Years since IPO: 15/15,
FFO Growth: 15/15,
FFO/share Growth: 15/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2025 Q1

Years since IPO: 15/15,
FFO Growth: 10/15,
FFO/share Growth: 0/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

Period: 2025 Q2

Years since IPO: 15/15,
FFO Growth: 10/15,
FFO/share Growth: 0/20,
Dividend Growth: 20/20,
Payout Ratio: 15/15,
Debt: 0/15
            

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's FFO

FFO Growth

Assessment of recent increases in FFO per share, indicating profitability

FFO/share Growth

Analysis of the recent Dividend track record

Dividend Growth

Payout level to determine if the dividend is safe

Payout Ratio

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

Saul Centers (BFS) Q2 EPS Drops 31%

BETHESDA, Md. , Aug. 7, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust ("REIT"), announced operating results for the quarter ended June 30, 2025 ("2025 Quarter").

Saul Centers, Inc. Reports Second Quarter 2025 Earnings

Highlights H1 2025 has seen significant strides in derisking key Bankable Feasibility Study (BFS) workstreams for the Jugan Project during H1 2025 including: Metallurgical test work. Trialling alternative processing techniques.

Besra Gold Announces Significant Strides in Jugan Project BFS H1 2025 Jugan Project Update

BETHESDA, Md. , June 12, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS) has declared a quarterly dividend of $0.59 per share on its common stock, to be paid on July 31, 2025, to holders of record on July 15, 2025.

Saul Centers Declares Quarterly Dividends

BETHESDA, Md. , May 8, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust ("REIT"), announced operating results for the quarter ended March 31, 2025 ("2025 Quarter").

Saul Centers, Inc. Reports First Quarter 2025 Earnings

-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation -Expands Amneal's extensive domestic pharmaceutical manufacturing footprint BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), an American biopharmaceutical company, and Apiject Systems, Corp. (“Apiject”), a medical technology company focused on advanced drug delivery, today announced a strategic collaboration to expand domestic production of Apiject's BFS-based injectable platform at Amneal's Brookhaven, NY facility.

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

BETHESDA, MD. , AUG. 7, 2025 /PRNEWSWIRE/ -- SAUL CENTERS, INC. (NYSE: BFS), AN EQUITY REAL ESTATE INVESTMENT TRUST ("REIT"), ANNOUNCED OPERATING RESULTS FOR THE QUARTER ENDED JUNE30, 2025 ("2025 QUARTER").

SAUL CENTERS, INC. REPORTS SECOND QUARTER 2025 EARNINGS

HIGHLIGHTS H1 2025 HAS SEEN SIGNIFICANT STRIDES IN DERISKING KEY BANKABLE FEASIBILITY STUDY (BFS) WORKSTREAMS FOR THE JUGAN PROJECT DURING H1 2025 INCLUDING: METALLURGICAL TEST WORK. TRIALLING ALTERNATIVE PROCESSING TECHNIQUES.

BESRA GOLD ANNOUNCES SIGNIFICANT STRIDES IN JUGAN PROJECT BFS H1 2025 JUGAN PROJECT UPDATE

BETHESDA, MD. , JUNE 12, 2025 /PRNEWSWIRE/ -- SAUL CENTERS, INC. (NYSE: BFS) HAS DECLARED A QUARTERLY DIVIDEND OF $0.59 PER SHARE ON ITS COMMON STOCK, TO BE PAID ON JULY 31, 2025, TO HOLDERS OF RECORD ON JULY 15, 2025.

SAUL CENTERS DECLARES QUARTERLY DIVIDENDS

BETHESDA, MD. , MAY 8, 2025 /PRNEWSWIRE/ -- SAUL CENTERS, INC. (NYSE: BFS), AN EQUITY REAL ESTATE INVESTMENT TRUST ("REIT"), ANNOUNCED OPERATING RESULTS FOR THE QUARTER ENDED MARCH 31, 2025 ("2025 QUARTER").

SAUL CENTERS, INC. REPORTS FIRST QUARTER 2025 EARNINGS

-ADDS BFS PLATFORM TECHNOLOGY TO PROVIDE LARGE-SCALE PRODUCTION CAPACITY FOR STERILE DRUG DOSAGE FORMS, INCLUDING INJECTABLES, OPHTHALMICS AND INHALATION -EXPANDS AMNEAL'S EXTENSIVE DOMESTIC PHARMACEUTICAL MANUFACTURING FOOTPRINT BRIDGEWATER, N.J., MAY 08, 2025 (GLOBE NEWSWIRE) -- AMNEAL PHARMACEUTICALS, INC. (NASDAQ: AMRX) (AMNEAL OR THE COMPANY), AN AMERICAN BIOPHARMACEUTICAL COMPANY, AND APIJECT SYSTEMS, CORP. (APIJECT), A MEDICAL TECHNOLOGY COMPANY FOCUSED ON ADVANCED DRUG DELIVERY, TODAY ANNOUNCED A STRATEGIC COLLABORATION TO EXPAND DOMESTIC PRODUCTION OF APIJECT'S BFS-BASED INJECTABLE PLATFORM AT AMNEAL'S BROOKHAVEN, NY FACILITY.

AMNEAL AND APIJECT TO EXPAND STERILE AND BLOW-FILL-SEAL (BFS) CAPABILITIES FOR ADVANCED PHARMACEUTICAL MANUFACTURING IN THE U.S.

BETHESDA, MD. , MARCH 6, 2025 /PRNEWSWIRE/ -- SAUL CENTERS, INC. (NYSE:BFS) HAS DECLARED A QUARTERLY DIVIDEND OF $0.59 PER SHARE ON ITS COMMON STOCK, TO BE PAID ON APRIL 30, 2025, TO HOLDERS OF RECORD ON APRIL 15, 2025.

BETHESDA, MD. , FEB. 28, 2025 /PRNEWSWIRE/ -- SAUL CENTERS, INC. (NYSE: BFS), AN EQUITY REAL ESTATE INVESTMENT TRUST ("REIT"), ANNOUNCED OPERATING RESULTS FOR THE QUARTER ENDED DECEMBER31, 2024 ("2024 QUARTER").

SAUL CENTERS, INC. REPORTS FOURTH QUARTER 2024 EARNINGS

BETHESDA, MD. , JAN. 23, 2025 /PRNEWSWIRE/ --SAUL CENTERS, INC. (NYSE: BFS),ANEQUITYREALESTATE INVESTMENTTRUST(REIT), ANNOUNCED TODAY THE INCOME TAX TREATMENT OF ITS 2024 DIVIDENDS.

SAUL CENTERS, INC. ANNOUNCES TAX TREATMENT OF 2024 DIVIDENDS

BETHESDA, MD. , DEC. 5, 2024 /PRNEWSWIRE/ -- SAUL CENTERS, INC. (NYSE:BFS) HAS DECLARED A QUARTERLY DIVIDEND OF $0.59 PER SHARE ON ITS COMMON STOCK, TO BE PAID ON JANUARY 31, 2025, TO HOLDERS OF RECORD ON JANUARY 15, 2025.

BETHESDA, MD. , NOV. 7, 2024 /PRNEWSWIRE/ -- SAUL CENTERS, INC. (NYSE: BFS), AN EQUITY REAL ESTATE INVESTMENT TRUST ("REIT"), ANNOUNCED OPERATING RESULTS FOR THE QUARTER ENDED SEPTEMBER30, 2024 ("2024 QUARTER").

Saul Centers

BFS

Price

Dividends

Yield

Dividends

No items found.

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Historical Scores

Press Releases

Related News, Articles and Videos

You might also be interested in

BFS.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Dividends

Yield

Dividends

No items found.

Financials Overview

Financial Reports

No items found.

Diversification by Property Type

Diversification by Country

Historical Scores

Press Releases

Related News, Articles and Videos

You might also be interested in

BFS